An invitation to share your views and inform the presentation of NICE guidance: breast cancer

Dear Colleague,

 

Thank you for previously registering an interest in supporting this NICE project to develop digital living guidelines. In supporting this broader work, the design project team are continuing to review how we present our guidance to ensure it is accessible to our users.

We are continuing to focus on how we can better present the content in our guidelines with initial focus on ‘NG101: Early and locally advanced breast cancer: diagnosis and management’. Our next round of user research will explore how to best structure our recommendations in the most logical order for our users. We have considered the needs of our users relayed from previous user feedback and started to design a potential structure to test with users.

 

We are keen to tap into the expertise of those with specialist knowledge in breast cancer. Yet please be reassured we are interested in involving those with varying experience of NICE guidance. Whatever your level of engagement or knowledge of NICE guidance, it would be great to hear your views, to help shape our future content.

 

What is involved?

It would be great to hear your feedback via this online survey. You can complete it when convenient to you. The survey will ask your opinion on the terminology we are using within the breast cancer topic, as well as understanding where you would expect to find specific information in our new navigational structure.

 

The survey will be open until 25/10/2022 so please submit your responses before then.

 

Please share with any colleagues and networks that you feel would also like to opportunity to participate; we hope to get feedback from as many potential users as possible.

 

Please do contact me if you have any questions.

 

Laura Delaney (she/her)

Audience insight manager

National Institute for Health and Care Excellence (NICE)

Level 1a – City Tower | Piccadilly Plaza | Manchester M1 4BT | United Kingdom

 

Phone:  +44 (0) 161 219 3790

Web : www.nice.org.uk

 

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article